A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.
about
Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcomaMicroRNA-335 and its target Rock1 synergistically influence tumor progression and prognosis in osteosarcoma.Osteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors.Theranostic Profiling for Actionable Aberrations in Advanced High Risk Osteosarcoma with Aggressive Biology Reveals High Molecular Diversity: The Human Fingerprint HypothesisMeta-analysis of the prognostic value of smad4 immunohistochemistry in various cancers.Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas.The effect of Zhangfei/CREBZF on cell growth, differentiation, apoptosis, migration, and the unfolded protein response in several canine osteosarcoma cell lines.Raman spectroscopy for grading of live osteosarcoma cells.Prognostic implications of RB1 tumour suppressor gene alterations in the clinical outcome of human osteosarcoma: a meta-analysis.A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.Significance of MTA1 in the molecular characterization of osteosarcoma.Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal.Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma.Screening of candidate key genes associated with human osteosarcoma using bioinformatics analysisComparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.Comment on Fu et al.: A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.Hedgehog signalling in the tumourigenesis and metastasis of osteosarcoma, and its potential value in the clinical therapy of osteosarcoma.
P2860
Q28072875-3E8680F9-A698-4C84-9CED-22705240CBC5Q33684869-D2DADBDD-7367-49E7-BD5E-FA9A68E781AEQ33735680-E937E88E-18B6-40B1-8A30-AF8849D83848Q34025926-BB2DD5E6-5271-4AC1-AAAC-AE82C1D5AA68Q34344060-B888E856-B910-4EC6-B9F2-4298C76BA1E4Q34501943-C4D0CF20-C106-420C-9BB7-96493A701563Q35137803-2716F7F3-6E18-49BF-9F19-5D4F5A74F71AQ35233163-109245AA-DEE3-4322-BF4F-5E68885E89D2Q35609180-990944FA-6A17-4FF0-8789-419EC7ED929FQ35652055-5D876768-D479-4781-9144-2305701735FCQ35821807-05D83F3A-18DD-4DDA-A2CD-04AE2892B244Q38191841-5A2B16AF-7B29-47D1-BCBA-EE373C15BA98Q38260257-E61ECF66-DE05-4193-8388-B8B1DF156E34Q38349935-4DB53C81-B538-4219-A4AC-790BE45DFD17Q38648115-C8A7E659-2A4E-41DE-8FF5-45BB1C9B7A81Q41611482-3364E189-B3C3-45D1-A4AA-40175BA074E4Q42634367-F8FD2280-E51B-430B-BAC2-7D79D1E68D42Q44682660-05CB016B-FB34-4662-AC7D-0F9FBC800027Q55105367-CE10073D-9997-4D70-ABB3-9518E00996A3
P2860
A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.
@en
type
label
A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.
@en
prefLabel
A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.
@en
P2093
P2860
P1433
P1476
A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.
@en
P2093
P2860
P2888
P304
P356
10.1007/S13277-013-0966-X
P577
2013-09-07T00:00:00Z
P6179
1004216767